• Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues


Evolve Biologics Establishes Sachse, Texas, Manufacturing Facility

Evolve Biologics Inc., an innovative plasma-derived therapeutics company, broke ground on its first manufacturing facility in Sachse, Texas. The project is expected to create 300 jobs over the next three years.

The new 200,000 sq. ft. location will initially have production capacity to process one million liters of plasma annually, with a planned expansion to two million liters.

“Today marks another significant milestone for Evolve as we take the next step towards the commercialization of our products and our goal of bringing critical plasma proteins to patients who need them,” said Jim Caggiano, CEO of Evolve. “Evolve’s patented next-generation technology, PlasmaCap EBA, is poised to revolutionize the plasma-derived therapeutics industry by harvesting significantly higher yields of these valuable proteins from human plasma through a cleaner, more efficient process, when compared to existing fractionation technologies. The state-of-the art Sachse facility, powered by our PlasmaCap EBA technology, will be the foundation of our future growth and global strategy.”

This state-of-the-art facility will be the first to use Evolve’s innovative and proprietary technology, PlasmaCap EBA, to commercially produce plasma-derived therapeutics, initially Intravenous Immunoglobulin and Human Serum Albumin.

“We are thrilled to welcome Evolve Biologics to Sachse as they grow to bring innovative therapeutic solutions to patients across the globe and deepen their roots here in Sachse,” added Gina Nash, City Manager for Sachse. “Evolve is a great addition to our local community, the region and the state of Texas. We welcome them as a neighbor, contributing to our local economy and supporting Texas’s continued growth, particularly in the biotechnology space.”

Exclusive Research